Increased urinary free immunoglobulin light chain excretion in patients with multiple sclerosis

Journal of Neuroimmunology

Volumn 220, Issue 1-2, 2010, Pages 99-103

  Dobson, Ruth ^a   Miller, R F ^b   Palmer, H E ^c,d   Feldmann, M ^e   Thompson, E J ^f   Thompson, A J ^f   Miller, D H ^f   Giovannoni, G ^a,f  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

^d University Hospitals   (United Kingdom)

^e UNIVERSITY OF OXFORD   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

HIV 1; Nitrate; Nitrite; Posterior uveitis; Rheumatoid arthritis; Urine

Indexed keywords

GADOLINIUM; IMMUNOGLOBULIN LIGHT CHAIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DEMYELINATING DISEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; URINARY EXCRETION; UVEITIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ARTHRITIS, RHEUMATOID; BIOLOGICAL MARKERS; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULINS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREDICTIVE VALUE OF TESTS; UP-REGULATION; UVEITIS, POSTERIOR;

EID: 77649185635     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.01.012     Document Type: Article

References (33)

1. Arnett F., Edworthy S., Bloch D., Mcshane D., Fries J., Cooper N., Healey L., Kaplan S., Liang M., and Luthra H. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31 (1988) 315-324
2. Cooper A., and Bluestone R. Free immunoglobulin light chains in connective tissue diseases. Ann. Rheum. Dis. 27 (1968) 537-543
3. Cotton F., Weiner H., Jolesz F., and Guttmann C. MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 60 (2003) 640-646
4. De Milito A., Nilsson A., Titanji K., Thorstensson R., Reizenstein E., Narita M., Grutzmeier S., Sönnerborg A., and Chiodi F. Mechanisms of hypergammaglobulinemia and impaired antigen-specific humoral immunity in HIV-1 infection. Blood 103 (2004) 2180-2186
5. Elovaara I., Seppälä I., Kinnunen E., and Laaksovirta H. Increased occurrence of free immunoglobulin light chains in cerebrospinal fluid and serum in human immunodeficiency virus-1 infection. J. Neuroimmunol. 35 (1991) 65-77
6. Felson D., Anderson J., Boers M., Bombardier C., Chernoff M., Fried B., Furst D., Goldsmith C., Kieszak S., and Lightfoot R. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials. Arthritis Rheum. 36 (1993) 729-740
7. Filomena C. Oligoclonal banding detected by urinary protein electrophoresis and immunofixation in two patients with the acquired immune deficiency syndrome and proteinuria. Clin. Chem. 35 (1989) 1795-1798
8. Franciotta D., Salvetti M., Lolli F., Serafini B., and Aloisi F. B cells and multiple sclerosis. Lancet Neurol. 7 (2008) 852-858
9. Freedman M.S., Thompson E.J., Deisenhammer F., Giovannoni G., Grimsley G., Keir G., Ohman S., Racke M.K., Sharief M., Sindic C.J., Sellebjerg F., and Tourtellotte W.W. Recommended standard of cerebrospinal fluid analysis in the diagnosis of multiple sclerosis: a consensus statement. Arch. Neurol. 62 (2005) 865-870
10. Ghose T., Quigley J., Landrigan P., and Asif A. Immunoglobulins in aqueous humour and iris from patients with endogenous uveitis and patients with cataract. Br. J. Ophthalmol. 57 (1973) 897-903
11. Giovannoni G., Heales S., Silver N., O'riordan J., Miller R., Land J., Clark J., and Thompson E. Raised serum nitrate and nitrite levels in patients with multiple sclerosis. J. Neurol. Sci. 145 (1997) 77-81
12. Giovannoni G., Silver N., O'riordan J., Miller R., Heales S., Land J., Elliot M., Feldmann M., Miller D., and Thompson E. Increased urinary nitric oxide metabolites in patients with multiple sclerosis correlates with early and relapsing disease. Mult. Scler. 5 (1999) 335-341
13. Giovannoni G., Silver N., Good C., Miller D., and Thompson E. Immunological time-course of gadolinium-enhancing MRI lesions in patients with multiple sclerosis. Eur. Neurol. 44 (2000) 222-228
14. Hauser S., Waubant E., Arnold D., Vollmer T., Antel J., Fox R., Bar-Or A., Panzara M., Sarkar N., Agarwal S., Langer-Gould A., and Smith C. B-cell depletion with rituximab in relapsing-remitting multiple sclerosis. N. Engl. J. Med. 358 (2008) 676-688
15. Ingle G., Sastre-Garriga J., Miller D., and Thompson A. Is inflammation important in early PPMS? A longitudinal MRI study. J. Neurol. Neurosurg. Psychiatry. 76 (2005) 1255-1258
16. Kahn S. Urinary "oligoclonal" bands in AIDS. Clin. Chem. 36 (1990) 174-175
17. Kappos L., Moeri D., Radue E., Schoetzau A., Schweikert K., Barkhof F., Miller D., Guttmann C., Weiner H., Gasperini C., and Filippi M. Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group. Lancet 353 (1999) 964-969
18. Kelly C., Baird G., Foster H., Hosker H., and Griffiths I. Prognostic significance of paraproteinaemia in rheumatoid arthritis. Ann. Rheum. Dis. 50 (1991) 290-294
19. Kurtzke J. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33 (1983) 1444-1452
20. Lublin F., and Reingold S. Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis. Neurology 46 (1996) 907-911
21. Magliozzi R., Howell O., Vora A., Serafini B., Nicholas R., Puopolo M., Reynolds R., and Aloisi F. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 130 (2007) 1089-1104
22. McFarland H. The B cell-old player, new position on the team. N. Engl. J. Med. 358 (2008) 664-665
23. Mehta P., Cook S., Troiano R., and Coyle P. Increased free light chains in the urine from patients with multiple sclerosis. Neurology 41 (1991) 540-544
24. Miller D., Albert P., Barkhof F., Francis G., Frank J., Hodgkinson S., Lublin F., Paty D., Reingold S., and Simon J. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force. Ann. Neurol. 39 (1996) 6-16
25. Murray P., Hoekzema R., Luyendijk L., Konings S., and Kijlstra A. Analysis of aqueous humor immunoglobulin G in uveitis by enzyme-linked immunosorbent assay, isoelectric focusing, and immunoblotting. Invest. Ophthalmol. Vis. Sci. 31 (1990) 2129-2135
26. Pezzoli A., and Pascali E. Bence Jones proteinuria in multiple sclerosis. Clin. Chem. 33 (1987) 1923-1924
27. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., Johnson K.P., Sibley W.A., Silberberg D.H., and Tourtellotte W.W. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann. Neurol. 13 (1983) 227-231
28. Presslauer S., Milosavljevic D., Brücke T., Bayer P., and Hübl W. Elevated levels of kappa free light chains in CSF support the diagnosis of multiple sclerosis. J. Neurol. 255 (2008) 1508-1514
29. Rinker J.N., Trinkaus K., and Cross A. Elevated CSF free kappa light chains correlate with disability prognosis in multiple sclerosis. Neurology 67 (2006) 1288-1290
30. Rudick R., Peter D., Bidlack J., and Knutson D. Multiple sclerosis: free light chains in cerebrospinal fluid. Neurology 35 (1985) 1443-1449
31. Sormani, M., Rovaris, M., Comi, G., Filippi, M. 2009. A reassessment of the plateauing relationship between T2 lesion load and disability in MS. Neurology.
32. Tintore M., Rovira A., Rio J., Tur C., Pelayo R., Nos C., Tellez N., Perkal H., Comabella M., Sastre-Garriga J., and Montalban X. Do oligoclonal bands add information to MRI in first attacks of multiple sclerosis. Neurology 13 2 (2008) 1079-1083
33. Tsai C., Wu T., Sun K., Lin W., and Yu C. Increased excretion of soluble interleukin 2 receptors and free light chain immunoglobulins in the urine of patients with active lupus nephritis. Ann. Rheum. Dis. 51 (1992) 168-172